Funding for this research was provided by:
FAPEMIG (APQ 03266-13/APQ 00094-12)
National Research Council CNPq (CNPq 446796/2014 and 310174/2017-7)
Received: 28 February 2019
Accepted: 31 May 2019
First Online: 25 June 2019
Ethics approval and consent to participate
: This study was approved by the UFMG Research Ethics Committee (CAAE – 06611912.8.0000.5149). The consent to participate requirement was waived by the ethics committee, since clinical, sociodemographic and epidemiological data from patients were not included, and the studies were performed using DNA from culture and not extracted from clinical samples.
: Not applicable.
: The authors declare that they have no competing interests.